Protein Pathway Discovery Could Restore Brain Growth

Researchers identified a protein linked to brain development delays in Angelman syndrome mouse models.

Updated on Oct. 21, 2026 in Autism

Protein Pathway Discovery Could Restore Brain Growth

Live Poll

Do you believe new research on rare genetic diseases will lead to successful human treatments?

Researchers have linked elevated levels of the protein asparagine synthetase to impaired brain growth in mice models of Angelman syndrome. This discovery offers a new potential target for future treatments for this genetic condition, which affects roughly one in 20,000 births.

Why it matters

The findings help explain why children with Angelman syndrome often experience smaller brain sizes. By identifying how a specific stress response halts development, researchers have pinpointed a biological pathway that could eventually lead to interventions.

This preclinical study identified 23 candidate proteins, finding that asparagine synthetase increases when the UBE3A gene is deactivated. Researchers successfully blocked this protein in mice to restore normal brain growth, though the work remains limited to mouse models.

The players

Washington University School of Medicine

A research institution located in St. Louis that investigates the cellular and genetic mechanisms of neurological conditions.

The details

In Angelman syndrome, the UBE3A gene is missing, which normally helps manage over 60 cellular processes. When UBE3A is gone, asparagine synthetase levels spike, triggering a stress response that forces neurons to conserve resources rather than grow. Blocking this protein effectively bypasses that stress reaction, allowing for improved brain development in the mice tested.

October 21, 2026: Study findings were published in Nature.
6 months of age: Cognitive and mobility deficits typically become evident in children.

Health Landscape

Angelman syndrome is characterized by the absence of the UBE3A gene, a deficit that impacts dozens of essential cellular processes. This finding marks the first time that asparagine synthetase has been linked to a neurological condition, representing a shift toward targeting specific protein pathways.

Families of children with Angelman syndrome should discuss these findings with a neurologist to understand how this research contributes to the long-term knowledge of the condition. While this work was conducted in mice, it highlights the importance of monitoring brain growth patterns in early childhood.

The takeaway

This discovery clarifies how a cellular stress response inhibits brain growth in Angelman syndrome. Caregivers should focus on tracking developmental milestones and discussing new research updates with their child's specialty care team.